Fundraising Fox

Biotech Series C Investors & VC Firms

600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.

Oregon Venture Fund
PortlandPre-Seed–Growth$500K – $5M
9 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
Calculus Capital Ltd.
LondonSeed–Late Stage$2.5M
24 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
14 people
Tesi (Finnish Industry Investment Ltd)
HelsinkiPre-Seed–Late Stage$5.4M – $16.2M
11 people
Bay City Capital
San RafaelSeed–Late Stage$5M – $10M
8 people
Beyond Ventures
Hong KongSeed–Growth$720K – $138M
16 people
Bootstrap Europe
LondonSeries A–Late Stage
19 people
Angel Bridge Co.,Ltd.
TokyoPre-Seed–Growth$792K – $62M
9 people
K2 HealthVentures
BostonSeries A–Late Stage$10M – $100M
22 people
DAYLI Partners
SeoulSeed–Late Stage
MassChallenge Mexico
BostonPre-Seed–Growth
29 people
TCG Crossover
Palo AltoSeed–Late Stage
25 people
European Circular Bioeconomy Fund
BonnSeries A–Late Stage$5.5M – $16.5M
24 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
27 people
Keio Innovation Initiative
TokyoSeed–Late Stage$1.5M – $64M
9 people
In-Q-Tel
TysonsSeed–Growth$100K – $2.5M
11 people
Argonautic Ventures
New YorkPre-Seed–Growth$5M
8 people
Booster Innovation Fund
WellingtonSeed–Growth
14 people
YFM Equity Partners
LondonSeed–Growth$3M – $15M
1 person
Alta Partners
JacksonSeed–Growth$1M – $12M
10 people
Asabys Partners
MadridSeed–Growth
20 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
venBio Partners
San FranciscoSeed–Late Stage
9 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.